LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer

NCT04560972 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Extensive Stage Lung Small Cell Carcinoma

Interventions

DRUG: Atezolizumab
DRUG: Carboplatin
DRUG: Etoposide
DRUG: Protein Phosphatase 2A Inhibitor LB-100

Sponsor

City of Hope Medical Center

Collaborators

[object Object]